Blake Borgeson insider trades

Open-market stock purchases and sales by Blake Borgeson, Director at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 15, 2021.

Recent trades

DateStockTradeValue
Sep 1, 2026RXRX Recursion Pharmaceuticals, IncSold$100K
Aug 4, 2026RXRX Recursion Pharmaceuticals, IncSold$97.5K
Jul 7, 2026RXRX Recursion Pharmaceuticals, IncSold$159K
Jun 17, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Jun 2, 2026RXRX Recursion Pharmaceuticals, IncSold$110K
May 5, 2026RXRX Recursion Pharmaceuticals, IncSold$106K
Apr 7, 2026RXRX Recursion Pharmaceuticals, IncSold$93K
Mar 3, 2026RXRX Recursion Pharmaceuticals, IncSold$588K
Feb 3, 2026RXRX Recursion Pharmaceuticals, IncSold$924K
Jan 6, 2026RXRX Recursion Pharmaceuticals, IncSold$959K
Dec 2, 2025RXRX Recursion Pharmaceuticals, IncSold$961K

Companies traded

  • RXRX Recursion Pharmaceuticals, Inc: 72 sales, last Sep 1, 2026

Get free alerts when Blake Borgeson files a new trade →